Abstract
Introduction: We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with a reduction in premenopausal urinary estrone glucuronide levels and a modest reduction in risk of breast cancer in women age ≤50 years. Methods: We further investigated the association of rs10235235 with breast cancer risk in a large case control study of 47,346 cases and 47,570 controls from 52 studies participating in the Breast Cancer Association Consortium. Genotyping of rs10235235 was conducted using a custom Illumina Infinium array. Stratified analyses were conducted to determine whether this association was modified by age at diagnosis, ethnicity, age at menarche or tumor characteristics. Results: We confirmed the association of rs10235235 with breast cancer risk for women of European ancestry but found no evidence that this association differed with age at diagnosis. Heterozygote and homozygote odds ratios (ORs) were OR = 0.98 (95% CI 0.94, 1.01; P = 0.2) and OR = 0.80 (95% CI 0.69, 0.93; P = 0.004), respectively (Ptrend = 0.02). There was no evidence of effect modification by tumor characteristics. rs10235235 was, however, associated with age at menarche in controls (Ptrend = 0.005) but not cases (Ptrend = 0.97). Consequently the association between rs10235235 and breast cancer risk differed according to age at menarche (Phet = 0.02); the rare allele of rs10235235 was associated with a reduction in breast cancer risk for women who had their menarche age ≥15 years (ORhet = 0.84, 95% CI 0.75, 0.94; ORhom = 0.81, 95% CI 0.51, 1.30; Ptrend = 0.002) but not for those who had their menarche age ≤11 years (ORhet = 1.06, 95% CI 0.95, 1.19, ORhom = 1.07, 95% CI 0.67, 1.72; Ptrend = 0.29). Conclusions: To our knowledge rs10235235 is the first single nucleotide polymorphism to be associated with both breast cancer risk and age at menarche consistent with the well-documented association between later age at menarche and a reduction in breast cancer risk. These associations are likely mediated via an effect on circulating hormone levels.
Original language | English |
---|---|
Article number | R51 |
Number of pages | 13 |
Journal | Breast Cancer Research |
Volume | 16 |
Issue number | 1 |
DOIs | |
Publication status | Published - 26 May 2014 |
Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Breast Cancer Research, Vol. 16, No. 1, R51, 26.05.2014.
Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Genetic variation at CYP3A is associated with age at menarche and breast cancer risk
T2 - A case-control study
AU - Johnson, Nichola
AU - Dudbridge, Frank
AU - Orr, Nick
AU - Gibson, Lorna
AU - Jones, Michael E.
AU - Schoemaker, Minouk J.
AU - Folkerd, Elizabeth J.
AU - Haynes, Ben P.
AU - Hopper, John L.
AU - Southey, Melissa C.
AU - Dite, Gillian S
AU - Apicella, Carmel
AU - Schmidt, Marjanka K.
AU - Broeks, Annegien
AU - Van't Veer, Laura J.
AU - Atsma, Femke
AU - Muir, Kenneth
AU - Lophatananon, Artitaya
AU - Fasching, Peter A.
AU - Beckmann, Matthias W.
AU - Ekici, Arif B
AU - Renner, Stefan P
AU - Sawyer, Elinor J
AU - Tomlinson, Ian P
AU - Kerin, Michael
AU - Miller, Nicola
AU - Burwinkel, Barbara
AU - Marme, Frederik
AU - Schneeweiss, Andreas
AU - Sohn, Christof
AU - Guénel, Pascal
AU - Truong, Therese
AU - Cordina-Duverger, Emilie
AU - Menegaux, Florence
AU - Bojesen, Stig E
AU - Nordestgaard, Børge G.
AU - Flyger, Henrik
AU - Milne, Roger L
AU - Zamora, Pilar M.
AU - Perez, Jose Ignacio Arias
AU - Benitez, Javier
AU - Bernstein, Leslie
AU - Anton-Culver, Hoda
AU - Ziogas, Argyrios
AU - Dur, Christina Clarke
AU - Brenner, Hermann
AU - Müller, Heiko
AU - Arndt, Volker
AU - Dieffenbach, Aida Karina
AU - Meindl, Alfons
AU - Heil, Joerg
AU - Bartram, Claus R.
AU - Schmutzler, Rita K.
AU - Brauch, Hiltrud
AU - Justenhoven, Christina
AU - Ko, Yon-Dschun
AU - Nevanlinna, Heli
AU - Muranen, Taru A.
AU - Aittomäki, Kristiina
AU - Blomqvist, Carl
AU - Matsuo, Keitaro
AU - Dörk, Thilo
AU - Bogdanova, Natalia V.
AU - Antonenkova, Natalia
AU - Lindblom, Annika
AU - Mannermaa, Arto
AU - Kataja, Vesa
AU - Kosma, Veli-Matti
AU - Hartikainen, Jaana M.
AU - Chenevix-Trench, Georgia
AU - Beesley, Jonathan
AU - Wu, Anna H
AU - Berg, David
AU - Tseng, Chiu-Chen
AU - Lambrechts, Diether
AU - Smeets, Dominiek
AU - Neven, Patrick
AU - Wildiers, Hans
AU - Chang-Claude, Jenny
AU - Rudolph, Anja
AU - Nickels, Stefan
AU - Flesch-Janys, Dieter
AU - Radice, Paolo
AU - Peterlongo, Paolo
AU - Bonanni, Bernardo
AU - Pensotti, Valeria
AU - Couch, Fergus J
AU - Olson, Janet E
AU - Wang, Xianshu
AU - Fredericksen, Zachary
AU - Pankratz, Vernon S.
AU - Giles, Graham G.
AU - Severi, Gianluca
AU - Baglietto, Laura
AU - Haiman, Chris
AU - Simard, Jacques
AU - Goldberg, Mark S.
AU - Labrèche, France
AU - Dumont, Martine
AU - Soucy, Penny
AU - Teo, Soo-Hwang
AU - Yip, Cheng Har
AU - Phuah, Sze Yee
AU - Cornes, Belinda K.
AU - Kristensen, Vessela N.
AU - Alnæs, Grethe Grenaker
AU - Børresen-Dale, Anne Lise
AU - Zheng, Wei
AU - Winqvist, Robert
AU - Pylkäs, Katri
AU - Jukkola-Vuorinen, Arja
AU - Grip, Mervi
AU - Andrulis, Irene L
AU - Knight, Julia A
AU - Glendon, Gord
AU - Mulligan, Anna Marie
AU - Devillee, Peter
AU - Figueroa, Jonine D
AU - Chanock, Stephen J
AU - Lissowska, Jolanta
AU - Sherman, Mark E
AU - Hall, Per
AU - Schoof, Nils
AU - Hooning, Maartje J
AU - Hollestelle, Antoinette
AU - Oldenburg, Rogier A.
AU - Tilanus-Linthorst, Madeleine M A
AU - Liu, Jianjun
AU - Cox, Angie
AU - Brock, Ian W.
AU - Reed, Malcolm W R
AU - Cross, Simon S
AU - Blot, William
AU - Signorello, Lisa B.
AU - Pharoah, Paul D P
AU - Dunning, Alison M
AU - Shah, Mitul
AU - Kang, Daehee
AU - Noh, Dong-Young
AU - Park, Sue K.
AU - Choi, Ji Yeob
AU - Hartman, Mikael
AU - Miao, Hui
AU - Lim, Wei Yen
AU - Tang, Anthony
AU - Hamann, Ute
AU - Försti, Asta
AU - Rüdiger, Thomas
AU - Ulmer, Hans Ulrich
AU - Jakubowska, Anna
AU - Lubinski, Jan
AU - Jaworska-Bieniek, Katarzyna
AU - Durda, Katarzyna
AU - Sangrajrang, Suleeporn
AU - Gaborieau, Valerie
AU - Brennan, Paul
AU - McKay, James
AU - Slager, Susan
AU - Toland, Amanda E.
AU - Vachon, Celine M
AU - Yannoukakos, Drakoulis
AU - Shen, Chen-Yang
AU - Yu, Jyh-Cherng
AU - Huang, Chiun Sheng
AU - Hou, Ming-Feng
AU - González-Neira, Anna
AU - Tessier, Daniel C.
AU - Vincent, Daniel
AU - Bacot, Francois
AU - Luccarini, Craig
AU - Dennis, Joe
AU - Michailidou, Kyriaki
AU - Bolla, Manjeet K.
AU - Wang, Jean S
AU - Easton, Douglas F
AU - García-Closas, Montserrat
AU - Dowsett, Mitch
AU - Ashworth, Alan
AU - Swerdlow, Anthony J
AU - Peto, Julian
AU - Silva, Isabel Dos Santos
AU - Fletcher, Olivia
AU - The GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network
AU - kConFab Investigators
AU - Australian Ovarian Cancer Study Group (AOCS)
PY - 2014/5/26
Y1 - 2014/5/26
N2 - Introduction: We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with a reduction in premenopausal urinary estrone glucuronide levels and a modest reduction in risk of breast cancer in women age ≤50 years. Methods: We further investigated the association of rs10235235 with breast cancer risk in a large case control study of 47,346 cases and 47,570 controls from 52 studies participating in the Breast Cancer Association Consortium. Genotyping of rs10235235 was conducted using a custom Illumina Infinium array. Stratified analyses were conducted to determine whether this association was modified by age at diagnosis, ethnicity, age at menarche or tumor characteristics. Results: We confirmed the association of rs10235235 with breast cancer risk for women of European ancestry but found no evidence that this association differed with age at diagnosis. Heterozygote and homozygote odds ratios (ORs) were OR = 0.98 (95% CI 0.94, 1.01; P = 0.2) and OR = 0.80 (95% CI 0.69, 0.93; P = 0.004), respectively (Ptrend = 0.02). There was no evidence of effect modification by tumor characteristics. rs10235235 was, however, associated with age at menarche in controls (Ptrend = 0.005) but not cases (Ptrend = 0.97). Consequently the association between rs10235235 and breast cancer risk differed according to age at menarche (Phet = 0.02); the rare allele of rs10235235 was associated with a reduction in breast cancer risk for women who had their menarche age ≥15 years (ORhet = 0.84, 95% CI 0.75, 0.94; ORhom = 0.81, 95% CI 0.51, 1.30; Ptrend = 0.002) but not for those who had their menarche age ≤11 years (ORhet = 1.06, 95% CI 0.95, 1.19, ORhom = 1.07, 95% CI 0.67, 1.72; Ptrend = 0.29). Conclusions: To our knowledge rs10235235 is the first single nucleotide polymorphism to be associated with both breast cancer risk and age at menarche consistent with the well-documented association between later age at menarche and a reduction in breast cancer risk. These associations are likely mediated via an effect on circulating hormone levels.
AB - Introduction: We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with a reduction in premenopausal urinary estrone glucuronide levels and a modest reduction in risk of breast cancer in women age ≤50 years. Methods: We further investigated the association of rs10235235 with breast cancer risk in a large case control study of 47,346 cases and 47,570 controls from 52 studies participating in the Breast Cancer Association Consortium. Genotyping of rs10235235 was conducted using a custom Illumina Infinium array. Stratified analyses were conducted to determine whether this association was modified by age at diagnosis, ethnicity, age at menarche or tumor characteristics. Results: We confirmed the association of rs10235235 with breast cancer risk for women of European ancestry but found no evidence that this association differed with age at diagnosis. Heterozygote and homozygote odds ratios (ORs) were OR = 0.98 (95% CI 0.94, 1.01; P = 0.2) and OR = 0.80 (95% CI 0.69, 0.93; P = 0.004), respectively (Ptrend = 0.02). There was no evidence of effect modification by tumor characteristics. rs10235235 was, however, associated with age at menarche in controls (Ptrend = 0.005) but not cases (Ptrend = 0.97). Consequently the association between rs10235235 and breast cancer risk differed according to age at menarche (Phet = 0.02); the rare allele of rs10235235 was associated with a reduction in breast cancer risk for women who had their menarche age ≥15 years (ORhet = 0.84, 95% CI 0.75, 0.94; ORhom = 0.81, 95% CI 0.51, 1.30; Ptrend = 0.002) but not for those who had their menarche age ≤11 years (ORhet = 1.06, 95% CI 0.95, 1.19, ORhom = 1.07, 95% CI 0.67, 1.72; Ptrend = 0.29). Conclusions: To our knowledge rs10235235 is the first single nucleotide polymorphism to be associated with both breast cancer risk and age at menarche consistent with the well-documented association between later age at menarche and a reduction in breast cancer risk. These associations are likely mediated via an effect on circulating hormone levels.
UR - http://www.scopus.com/inward/record.url?scp=85016045726&partnerID=8YFLogxK
U2 - 10.1186/bcr3662
DO - 10.1186/bcr3662
M3 - Article
C2 - 24887515
AN - SCOPUS:85016045726
SN - 1465-542X
VL - 16
JO - Breast Cancer Research
JF - Breast Cancer Research
IS - 1
M1 - R51
ER -